Eavi2020

The European AIDS Vaccine Initiative (EAVI2020) was a 23 million euro initiative to accelerate the search for an effective HIV vaccine that ran from 2015-2022. This page will now longer be updated. Vaccines are the most powerful public health tools available. Developing safe, effective and affordable vaccines that can prevent HIV infection in uninfected people is the best hope for controlling and ultimately ending the HIV epidemic. Developing a therapeutic vaccine could also be beneficial for people living with HIV by helping slow the progression of the disease and prevent or delay the onset of AIDS. Scientists in this consortium are pooling their expertise to make this possible.